AstraZeneca filed with Invima the request for approval of emergency use for its vaccine – Health



[ad_1]

According to decree 1787 of 2020, which regulates the approval of emergency use of medicines and biologicals against covid-19 that have not definitively concluded their studies, Invima has a period of ten days to review the information provided by the company and to grant or reject the request for the use of the vaccine.

(Plus: A single dose of Pfizer vaccine would be 85% effective against covid-19)

To file an emergency use request, AstraZeneca must provide the clinical, efficacy and safety data it obtained in the biologics development trials and commit to updating it as new information becomes available.

Invima has already given emergency use authorization for the Pfizer vaccine and authorized the importation of Sinovac vaccines.

We recommend:

– The economic crisis of the hospital where the first covid vaccine was applied

– Suggest causes of brain covid or ‘brain fog’

ELTIEMPO.COM

Download the Weather app

News from Colombia and the world instantly: Customize, discover and learn.

KNOW MORE

Keep going down
to find more content

You got to content limit of the month

Enjoy the content of THE DIGITAL TIME unlimitedly. Subscribe now!

* COP $ 900 / month during the first two months

We know that you like to always be informed.

Create an account and you can enjoy:

  • Access to newsletters with the best current news.
  • Comment the news that interests you.
  • Keep your favorite items.

Create an account and you can enjoy our content from any device.



[ad_2]